| Date | Title | Description | Source |
| 24.10.2022 | Genenta Provides First Half 2022 Business Update and Financi... | Current dose escalation study data shows a median overall survival of 17 months
Adding cohort to Ph... | einpresswi... |
| 24.10.2022 | Genenta Provides First Half 2022 Business Update and Financi... | Current dose escalation study data shows a median overall survival of 17 months
Adding cohort to Pha... | globenewsw... |
| 05.10.2022 | Genenta to Present at Upcoming Scientific and Investor Confe... | MILAN, Italy and NEW YORK, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clini... | globenewsw... |
| 05.10.2022 | Genenta to Present at Upcoming Scientific and Investor Confe... | /EIN News/ -- MILAN, Italy and NEW YORK, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: ... | einpresswi... |
| 04.10.2022 | ROTH Capital Partners to Host Inaugural Healthcare Opportuni... | Event to feature company presentations and one-on-one meetings between institutional investors and s... | einpresswi... |
| 07.09.2022 | Genenta to Present at Upcoming Investor Conferences | MILAN, Italy and NEW YORK, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clin... | globenewsw... |
| 13.05.2022 | Genenta to Present at Upcoming Scientific Congresses ASGCT, ... | MILAN, Italy and NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinic... | globenewsw... |
| 04.05.2022 | Genenta Progresses to Higher Dosing Cohort in Temferon™ Phas... | No dose limiting toxicity observed in previous three dose level cohorts
Represents a 50% higher dose... | globenewsw... |
| 04.05.2022 | Genenta Files Annual Report on Form 20-F for Fiscal Year 202... | MILAN, Italy and NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (NASDAQ: GNTA), a... | globenewsw... |
| 02.05.2022 | Genenta ASGCT Clinical Data Highlights Temferon™ Biological ... | MILAN, Italy and NEW YORK, May 02, 2022 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinic... | globenewsw... |
| 27.04.2022 | Genenta Announces Nomination of Mark A. Sirgo as Chair | 35 years industry experience including as CEO and founder of public company
Stephen Squinto steps d... | globenewsw... |
| 20.04.2022 | Genenta to Host Expert Fireside Chat on Immuno Gene & Ce... | MILAN, Italy and NEW YORK, April 20, 2022 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clin... | globenewsw... |
| 15.12.2021 | Genenta Announces Pricing of Upsized Initial Public Offering | MILAN, Italy and NEW YORK, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Genenta Science S.p.A., a clinical-stag... | marketscre... |
| 14.12.2021 | Genenta Announces Pricing of Upsized Initial Public Offering | MILAN, Italy and NEW YORK, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Genenta Science S.p.A., a clinical-stag... | globenewsw... |
| 16.11.2021 | Genenta To Present Updated Phase I/II Data At Upcoming Scien... | MILAN, Italy and NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Genenta Science, a clinical-stage biote... | globenewsw... |
| 11.11.2021 | Genenta Announces Filing of Registration Statement for Propo... | MILAN, Italy and NEW YORK, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Genenta Science, a clinical-stage biote... | marketscre... |
| 10.11.2021 | Genenta Announces Filing of Registration Statement for Propo... | MILAN, Italy and NEW YORK, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Genenta Science, a clinical-stage biote... | globenewsw... |
| 30.09.2021 | Genenta Strengthens Senior Management With Key Strategic App... | Gaurav Shah, Brad Loncar and Alec Ross appointed as strategic advisors
Barbara Regonini joins recen... | marketscre... |
| 03.05.2021 | Genenta to Appoint Richard Slansky as CFO and Anthony Marucc... | MILAN, Italy and NEW YORK, May 03, 2021 (GLOBE NEWSWIRE) -- Genenta Science, a clinical-stage biotec... | marketscre... |
| 05.01.2021 | Genenta to Take Part in Gene Therapy Panel and Two Virtual I... | MILAN, Italy and NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Genenta Science, a clinical-stage biote... | marketscre... |
| 23.11.2020 | Genenta to Appoint Stephen Squinto, Experienced Biotech Exec... | MILAN, Italy and NEW YORK, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Genenta Science, a clinical-stage biote... | marketscre... |
| 16.11.2020 | Genenta's Temferon™: Evidence of Controlled and Targeted Int... | MILAN, Italy and NEW YORK, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Genenta Science, a clinical-stage biote... | marketscre... |
| 30.09.2020 | Genenta to present preliminary Phase I/II clinical data on T... | MILAN, Italy and NEW YORK, Sept. 30, 2020 (GLOBE NEWSWIRE) -- Genenta Science, a clinical-stage biot... | marketscre... |
| 11.09.2019 | Genenta Science Raises €13.2M in Funding | Genenta Science, a Milan, Italy-based clinical-stage biotechnology company pioneering the developmen... | finsmes.co... |
| 17.09.2017 | Genenta Raises $8.4M in Second Financing | Genenta Science, a Milan, Italy-based biotech company committed to the development and commercializa... | finsmes.co... |
| 13.09.2017 | Martin Shkreli suddenly changes his tune on Clinton thr... | ⇨ Looking to stay out of jail ahead of his sentencing on three convictions on felony fraud char... | endpts.com... |
| 19.01.2017 | GSK R&D vet Russo jumps to Genenta, takes a lead role ... | Carlo Russo, Genenta
GSK vet Carlo Russo is joining up with some of his former gene therap... | endpts.com... |
| 16.09.2016 | Genenta and OSR Sign Collaboration Deal with Amgen | Venture capital backed Genenta Science (Milan, Italy) and San Raffaele Hospital and Scientific Insti... | finsmes.co... |
| 03.09.2015 | Genenta Science, Tiziana Mattioni Joins as COO | Genenta Science, a Milan, Italy-based biotech company focused on hematopoietic stem cell gene therap... | finsmes.co... |
| 06.03.2015 | Italy's Genenta Science raises $11M for gene therapy program... | Milan-based Genenta Science has raised $11 million for its work on a new gene therapy. According to ... | fiercebiot... |
| 05.03.2015 | Genenta Science Closes €10M Series A Financing | Genenta Science, a Milan, Italy-based biotech startup, closed its €10m ($11m) Series A financing.
T... | finsmes.co... |
| 23.01.2015 | Genenta Science Raises €6.2M in First Tranche of Series A Fu... | Genenta Science, a Milan, Italy-based biotech startup, raised €6.2m ($7.2m) in the first tranche of ... | finsmes.co... |
